Physician profile
Dwayne P Vanderberg
NPI 1225012008
$1,072.56
in general payments reported to CMS, 2019-2025
14 companies · $69.83 in 2025
The $69.83 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $130 · 2021: $97.46 · 2022: $224 · 2023: $312 · 2024: $21.30 · 2025: $69.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $278.96 | 2022-2023 | Ubrelvy, Qulipta, Linzess |
| Janssen Pharmaceuticals, INC | $229.12 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $166.10 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.66 | 2020 | |
| Sunovion Pharmaceuticals INC. | $74.98 | 2019 | |
| Pfizer INC. | $72.25 | 2019-2025 | |
| Hologic Sales and Service, LLC | $56.54 | 2024-2025 | Aptima |
| Cranial Technologies, INC | $19.10 | 2025 | Doc Band |
| Glaxosmithkline, LLC. | $17.51 | 2019 | |
| Merck Sharp & Dohme LLC | $17.50 | 2022 | |
| Allergan, INC. | $16.70 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $15.33 | 2019 | |
| Xeris Pharmaceuticals, INC. | $15.06 | 2023 | Gvoke Hypopen |
| Sanofi Pasteur INC. | $13.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwayne Vanderberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.